Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

DSpace Repository

Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

Author: Giladi, Nir; Alcalay, Roy N.; Cutter, Gary; Gasser, Thomas; Gurevich, Tanya; Hoeglinger, Guenter U.; Marek, Kenneth; Pacchetti, Claudio; Schapira, Anthony H., V; Scherzer, Clemens R.; Simuni, Tanya; Minini, Pascal; Sardi, S. Pablo; Peterschmitt, M. Judith
Tübinger Autor(en):
Gasser, Thomas
Published in: Lancet Neurology (2023), Bd. 22, H. 8, S. 661-671
Verlagsangabe: New York : Elsevier Science Inc
Language: English
Full text: https://doi.org/10.1016/S1474-4422(23)00205-3
ISSN: 1474-4422
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)